 | • レポートコード：QAF27724 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の人用ワクチン市場について種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン）、用途別（大人用、子供用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・人用ワクチン市場の概要 ・世界の主要地域別人用ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の人用ワクチン市場規模2016-2021：種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン） ・世界の人用ワクチン市場予測2012-2027：種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン） ・世界の人用ワクチン市場規模2016-2021：用途別（大人用、子供用） ・世界の人用ワクチン市場予測2012-2027：用途別（大人用、子供用） ・人用ワクチンのアメリカ市場規模と予測2016-2021 ・人用ワクチンのヨーロッパ市場規模と予測2016-2021 ・人用ワクチンの中国市場規模と予測2016-2021 ・人用ワクチンの日本市場規模と予測2016-2021 ・人用ワクチンの東南アジア市場規模と予測2016-2021 ・人用ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech） ・人用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・人用ワクチンの市場動向・機会・課題 ・調査の結論 |
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
China Human Vaccine is widely used for adults and children. The most proportion of China Human Vaccine is children, and the sales market share in 2017 is 64.6%.
Market Analysis and Insights: Global Human Vaccine Market
The global Human Vaccine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Human Vaccine Scope and Market Size
The global Human Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Segment by Application
Adults
Children
The Human Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
1 Human Vaccine Market Overview
1.1 Human Vaccine Product Scope
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Adults
1.3.3 Children
1.4 Human Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Vaccine Price Trends (2016-2027)
2 Human Vaccine Estimates and Forecasts by Region
2.1 Global Human Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Human Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Human Vaccine Estimates and Projections (2016-2027)
2.4.3 China Human Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Human Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2016-2027)
2.4.6 India Human Vaccine Estimates and Projections (2016-2027)
3 Global Human Vaccine Competition Landscape by Players
3.1 Global Top Human Vaccine Players by Sales (2016-2021)
3.2 Global Top Human Vaccine Players by Revenue (2016-2021)
3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2020)
3.4 Global Human Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Vaccine Market Size by Type
4.1 Global Human Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Human Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Human Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Vaccine Price by Type (2016-2021)
4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Human Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Vaccine Price Forecast by Type (2022-2027)
5 Global Human Vaccine Market Size by Application
5.1 Global Human Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Human Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Human Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Vaccine Price by Application (2016-2021)
5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Human Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Vaccine Price Forecast by Application (2022-2027)
6 North America Human Vaccine Market Facts & Figures
6.1 North America Human Vaccine Sales by Company
6.1.1 North America Human Vaccine Sales by Company (2016-2021)
6.1.2 North America Human Vaccine Revenue by Company (2016-2021)
6.2 North America Human Vaccine Sales Breakdown by Type
6.2.1 North America Human Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Human Vaccine Sales Breakdown by Application
6.3.1 North America Human Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Human Vaccine Market Facts & Figures
7.1 Europe Human Vaccine Sales by Company
7.1.1 Europe Human Vaccine Sales by Company (2016-2021)
7.1.2 Europe Human Vaccine Revenue by Company (2016-2021)
7.2 Europe Human Vaccine Sales Breakdown by Type
7.2.1 Europe Human Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Human Vaccine Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Human Vaccine Market Facts & Figures
8.1 China Human Vaccine Sales by Company
8.1.1 China Human Vaccine Sales by Company (2016-2021)
8.1.2 China Human Vaccine Revenue by Company (2016-2021)
8.2 China Human Vaccine Sales Breakdown by Type
8.2.1 China Human Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Human Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Human Vaccine Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Human Vaccine Market Facts & Figures
9.1 Japan Human Vaccine Sales by Company
9.1.1 Japan Human Vaccine Sales by Company (2016-2021)
9.1.2 Japan Human Vaccine Revenue by Company (2016-2021)
9.2 Japan Human Vaccine Sales Breakdown by Type
9.2.1 Japan Human Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Human Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Vaccine Market Facts & Figures
10.1 Southeast Asia Human Vaccine Sales by Company
10.1.1 Southeast Asia Human Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Human Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Human Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Human Vaccine Market Facts & Figures
11.1 India Human Vaccine Sales by Company
11.1.1 India Human Vaccine Sales by Company (2016-2021)
11.1.2 India Human Vaccine Revenue by Company (2016-2021)
11.2 India Human Vaccine Sales Breakdown by Type
11.2.1 India Human Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Human Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Human Vaccine Sales Breakdown by Application
11.3.1 India Human Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Human Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Vaccine Business
12.1 CNBG
12.1.1 CNBG Corporation Information
12.1.2 CNBG Business Overview
12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CNBG Human Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 Changsheng Life
12.2.1 Changsheng Life Corporation Information
12.2.2 Changsheng Life Business Overview
12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Changsheng Life Human Vaccine Products Offered
12.2.5 Changsheng Life Recent Development
12.3 Zhifei
12.3.1 Zhifei Corporation Information
12.3.2 Zhifei Business Overview
12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zhifei Human Vaccine Products Offered
12.3.5 Zhifei Recent Development
12.4 ChengDa Bio
12.4.1 ChengDa Bio Corporation Information
12.4.2 ChengDa Bio Business Overview
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 ChengDa Bio Human Vaccine Products Offered
12.4.5 ChengDa Bio Recent Development
12.5 Kangtai
12.5.1 Kangtai Corporation Information
12.5.2 Kangtai Business Overview
12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kangtai Human Vaccine Products Offered
12.5.5 Kangtai Recent Development
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Corporation Information
12.6.2 SINOVAC BIOTECH Business Overview
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
12.6.5 SINOVAC BIOTECH Recent Development
12.7 Hissen
12.7.1 Hissen Corporation Information
12.7.2 Hissen Business Overview
12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hissen Human Vaccine Products Offered
12.7.5 Hissen Recent Development
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Corporation Information
12.8.2 Walvax Biotechnology Business Overview
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Walvax Biotechnology Human Vaccine Products Offered
12.8.5 Walvax Biotechnology Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Business Overview
12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GSK Human Vaccine Products Offered
12.9.5 GSK Recent Development
12.10 SANOFI
12.10.1 SANOFI Corporation Information
12.10.2 SANOFI Business Overview
12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 SANOFI Human Vaccine Products Offered
12.10.5 SANOFI Recent Development
12.11 Rong An
12.11.1 Rong An Corporation Information
12.11.2 Rong An Business Overview
12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Rong An Human Vaccine Products Offered
12.11.5 Rong An Recent Development
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Corporation Information
12.12.2 NuoCheng Bio Business Overview
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 NuoCheng Bio Human Vaccine Products Offered
12.12.5 NuoCheng Bio Recent Development
12.13 Hualan Bio
12.13.1 Hualan Bio Corporation Information
12.13.2 Hualan Bio Business Overview
12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hualan Bio Human Vaccine Products Offered
12.13.5 Hualan Bio Recent Development
12.14 Tiantan biological
12.14.1 Tiantan biological Corporation Information
12.14.2 Tiantan biological Business Overview
12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Tiantan biological Human Vaccine Products Offered
12.14.5 Tiantan biological Recent Development
12.15 Changchun Baike
12.15.1 Changchun Baike Corporation Information
12.15.2 Changchun Baike Business Overview
12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Changchun Baike Human Vaccine Products Offered
12.15.5 Changchun Baike Recent Development
12.16 Adimmune
12.16.1 Adimmune Corporation Information
12.16.2 Adimmune Business Overview
12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Adimmune Human Vaccine Products Offered
12.16.5 Adimmune Recent Development
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Corporation Information
12.17.2 Zhongyianke Biotech Business Overview
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhongyianke Biotech Human Vaccine Products Offered
12.17.5 Zhongyianke Biotech Recent Development
13 Human Vaccine Manufacturing Cost Analysis
13.1 Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Vaccine
13.4 Human Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Vaccine Distributors List
14.3 Human Vaccine Customers
15 Market Dynamics
15.1 Human Vaccine Market Trends
15.2 Human Vaccine Drivers
15.3 Human Vaccine Market Challenges
15.4 Human Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Human Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Human Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Human Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Human Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Human Vaccine Sales Share by Company (2016-2021)
Table 14. Global Human Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020)
Table 17. Global Human Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Human Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Human Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Human Vaccine Sales Share by Type (2016-2021)
Table 23. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Vaccine Price (USD/Dose) by Type (2016-2021)
Table 25. Global Human Vaccine Sales Share by Type (2022-2027)
Table 26. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Human Vaccine Price (USD/Dose) by Type (2022-2027)
Table 29. Global Human Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Human Vaccine Sales Share by Application (2016-2021)
Table 31. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Vaccine Price (USD/Dose) by Application (2016-2021)
Table 33. Global Human Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Human Vaccine Sales Share by Application (2022-2027)
Table 35. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Human Vaccine Price (USD/Dose) by Application (2022-2027)
Table 38. North America Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Human Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Human Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Human Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Human Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Human Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Human Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Human Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Human Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Human Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Human Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Human Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Human Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Human Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Human Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Human Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Human Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Human Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Human Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Human Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Human Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Human Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Human Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Human Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Human Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Human Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Human Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Human Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Human Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Human Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Human Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Human Vaccine Sales Market Share by Application (2022-2027)
Table 110. CNBG Corporation Information
Table 111. CNBG Description and Business Overview
Table 112. CNBG Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. CNBG Human Vaccine Product
Table 114. CNBG Recent Development
Table 115. Changsheng Life Corporation Information
Table 116. Changsheng Life Description and Business Overview
Table 117. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Changsheng Life Human Vaccine Product
Table 119. Changsheng Life Recent Development
Table 120. Zhifei Corporation Information
Table 121. Zhifei Description and Business Overview
Table 122. Zhifei Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Zhifei Human Vaccine Product
Table 124. Zhifei Recent Development
Table 125. ChengDa Bio Corporation Information
Table 126. ChengDa Bio Description and Business Overview
Table 127. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. ChengDa Bio Human Vaccine Product
Table 129. ChengDa Bio Recent Development
Table 130. Kangtai Corporation Information
Table 131. Kangtai Description and Business Overview
Table 132. Kangtai Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Kangtai Human Vaccine Product
Table 134. Kangtai Recent Development
Table 135. SINOVAC BIOTECH Corporation Information
Table 136. SINOVAC BIOTECH Description and Business Overview
Table 137. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. SINOVAC BIOTECH Human Vaccine Product
Table 139. SINOVAC BIOTECH Recent Development
Table 140. Hissen Corporation Information
Table 141. Hissen Description and Business Overview
Table 142. Hissen Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Hissen Human Vaccine Product
Table 144. Hissen Recent Development
Table 145. Walvax Biotechnology Corporation Information
Table 146. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Walvax Biotechnology Description and Business Overview
Table 148. Walvax Biotechnology Human Vaccine Product
Table 149. Walvax Biotechnology Recent Development
Table 150. GSK Corporation Information
Table 151. GSK Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. GSK Description and Business Overview
Table 153. GSK Human Vaccine Product
Table 154. GSK Recent Development
Table 155. SANOFI Corporation Information
Table 156. SANOFI Description and Business Overview
Table 157. SANOFI Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. SANOFI Human Vaccine Product
Table 159. SANOFI Recent Development
Table 160. Rong An Corporation Information
Table 161. Rong An Description and Business Overview
Table 162. Rong An Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Rong An Human Vaccine Product
Table 164. Rong An Recent Development
Table 165. NuoCheng Bio Corporation Information
Table 166. NuoCheng Bio Description and Business Overview
Table 167. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. NuoCheng Bio Human Vaccine Product
Table 169. NuoCheng Bio Recent Development
Table 170. Hualan Bio Corporation Information
Table 171. Hualan Bio Description and Business Overview
Table 172. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. Hualan Bio Human Vaccine Product
Table 174. Hualan Bio Recent Development
Table 175. Tiantan biological Corporation Information
Table 176. Tiantan biological Description and Business Overview
Table 177. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Tiantan biological Human Vaccine Product
Table 179. Tiantan biological Recent Development
Table 180. Changchun Baike Corporation Information
Table 181. Changchun Baike Description and Business Overview
Table 182. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 183. Changchun Baike Human Vaccine Product
Table 184. Changchun Baike Recent Development
Table 185. Adimmune Corporation Information
Table 186. Adimmune Description and Business Overview
Table 187. Adimmune Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 188. Adimmune Human Vaccine Product
Table 189. Adimmune Recent Development
Table 190. Zhongyianke Biotech Corporation Information
Table 191. Zhongyianke Biotech Description and Business Overview
Table 192. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 193. Zhongyianke Biotech Human Vaccine Product
Table 194. Zhongyianke Biotech Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Human Vaccine Distributors List
Table 198. Human Vaccine Customers List
Table 199. Human Vaccine Market Trends
Table 200. Human Vaccine Market Drivers
Table 201. Human Vaccine Market Challenges
Table 202. Human Vaccine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Adults Examples
Figure 7. Children Examples
Figure 8. Global Human Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Human Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Human Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Human Vaccine Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 12. Global Human Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Human Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Human Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Human Vaccine Players Market Share by Revenue in Human Vaccine: 2016 & 2020
Figure 27. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Human Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Human Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Human Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Human Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Human Vaccine Sales Market Share by Type in 2020
Figure 33. North America Human Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Human Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Human Vaccine Sales Market Share by Application in 2020
Figure 36. China Human Vaccine Sales Market Share by Type in 2020
Figure 37. China Human Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Human Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Human Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Human Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Human Vaccine Sales Market Share by Application in 2020
Figure 42. India Human Vaccine Sales Market Share by Type in 2020
Figure 43. India Human Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Human Vaccine
Figure 46. Manufacturing Process Analysis of Human Vaccine
Figure 47. Human Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
ヒト狂犬病ワクチンのグローバル市場調査 2019年 The global Human Rabies Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Rabies Vaccine volume and value at global level, regional level and company level. From a global perspective, th…- A型肝炎ワクチンのグローバル市場2021 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines:…
- 世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
- 肺炎球菌ワクチンのグローバル市場2021 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…
- 7価肺炎球菌ワクチンのグローバル市場調査 2019年 The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a glob…